The protein encoded by this gene, a member of the G protein-coupled receptor family 1, is an integral plasma membrane protein which binds melanin-concentrating hormone. The encoded protein can inhibit cAMP accumulation and stimulate intracellular calcium flux, and is probably involved in the neuronal regulation of food consumption. Although structurally similar to somatostatin receptors, this protein does not seem to bind somatostatin.[1]
S-36057 - modified MCH 6-13 fragment substituted with 3-iodotyrosine at N-terminus via dioxyoctanoyl linker, used as 125I radioligand for mapping MCH1in vivo.[10][11]
↑Luthin DR (Jul 2007). "Anti-obesity effects of small molecule melanin-concentrating hormone receptor 1 (MCHR1) antagonists". Life Sciences. 81 (6): 423–40. doi:10.1016/j.lfs.2007.05.029. PMID17655875.
↑Rivera G, Bocanegra-García V, Galiano S, Cirauqui N, Ceras J, Pérez S, Aldana I, Monge A (2008). "Melanin-concentrating hormone receptor 1 antagonists: a new perspective for the pharmacologic treatment of obesity". Current Medicinal Chemistry. 15 (10): 1025–43. doi:10.2174/092986708784049621. PMID18393860.
↑Hervieu G (Aug 2003). "Melanin-concentrating hormone functions in the nervous system: food intake and stress". Expert Opinion on Therapeutic Targets. 7 (4): 495–511. doi:10.1517/14728222.7.4.495. PMID12885269.
↑Shimazaki T, Yoshimizu T, Chaki S (2006). "Melanin-concentrating hormone MCH1 receptor antagonists: a potential new approach to the treatment of depression and anxiety disorders". CNS Drugs. 20 (10): 801–11. doi:10.2165/00023210-200620100-00002. PMID16999451.
↑Hervieu GJ (Apr 2006). "Further insights into the neurobiology of melanin-concentrating hormone in energy and mood balances". Expert Opinion on Therapeutic Targets. 10 (2): 211–29. doi:10.1517/14728222.10.2.211. PMID16548771.
↑Smith DG, Davis RJ, Rorick-Kehn L, Morin M, Witkin JM, McKinzie DL, Nomikos GG, Gehlert DR (Jun 2006). "Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice". Neuropsychopharmacology. 31 (6): 1135–45. doi:10.1038/sj.npp.1300913. PMID16205780.
↑Roy M, David N, Cueva M, Giorgetti M (Jan 2007). "A study of the involvement of melanin-concentrating hormone receptor 1 (MCHR1) in murine models of depression". Biological Psychiatry. 61 (2): 174–80. doi:10.1016/j.biopsych.2006.03.076. PMID16934771.
↑Saito Y, Nagasaki H (2008). "The melanin-concentrating hormone system and its physiological functions". Results and Problems in Cell Differentiation. Results and Problems in Cell Differentiation. 46: 159–79. doi:10.1007/400_2007_052. ISBN978-3-540-78350-3. PMID18227983.
↑Able SL, Ivarsson M, Fish RL, Clarke TL, McCourt C, Duckworth JM, Napier C, Katugampola SD (Aug 2009). "Localisation of melanin-concentrating hormone receptor 1 in rat brain and evidence that sleep parameters are not altered despite high central receptor occupancy". European Journal of Pharmacology. 616 (1–3): 101–6. doi:10.1016/j.ejphar.2009.06.009. PMID19540226.
↑Chaki S, Yamaguchi J, Yamada H, Thomsen W, Tran TA, Semple G, Sekiguchi Y (2005). "ATC0175: an orally active melanin-concentrating hormone receptor 1 antagonist for the potential treatment of depression and anxiety". CNS Drug Reviews. 11 (4): 341–52. doi:10.1111/j.1527-3458.2005.tb00052.x. PMID16614734.
↑Gehlert DR, Rasmussen K, Shaw J, Li X, Ardayfio P, Craft L, Coskun T, Zhang HY, Chen Y, Witkin JM (May 2009). "Preclinical evaluation of melanin-concentrating hormone receptor 1 antagonism for the treatment of obesity and depression". The Journal of Pharmacology and Experimental Therapeutics. 329 (2): 429–38. doi:10.1124/jpet.108.143362. PMID19182070.
↑Doggrell SA (Jun 2003). "Does the melanin-concentrating hormone antagonist SNAP-7941 deserve 3As?". Expert Opinion on Investigational Drugs. 12 (6): 1035–8. doi:10.1517/13543784.12.6.1035. PMID12783607.
↑David DJ, Klemenhagen KC, Holick KA, Saxe MD, Mendez I, Santarelli L, Craig DA, Zhong H, Swanson CJ, Hegde LG, Ping XI, Dong D, Marzabadi MR, Gerald CP, Hen R (Apr 2007). "Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis". The Journal of Pharmacology and Experimental Therapeutics. 321 (1): 237–48. doi:10.1124/jpet.106.109678. PMID17237257.
↑Takekawa S, Asami A, Ishihara Y, Terauchi J, Kato K, Shimomura Y, Mori M, Murakoshi H, Kato K, Suzuki N, Nishimura O, Fujino M (Mar 2002). "T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist". European Journal of Pharmacology. 438 (3): 129–35. doi:10.1016/S0014-2999(02)01314-6. PMID11909603.
Further reading
Kolakowski LF, Jung BP, Nguyen T, Johnson MP, Lynch KR, Cheng R, Heng HH, George SR, O'Dowd BF (Dec 1996). "Characterization of a human gene related to genes encoding somatostatin receptors". FEBS Letters. 398 (2–3): 253–8. doi:10.1016/S0014-5793(96)01160-X. PMID8977118.
Chambers J, Ames RS, Bergsma D, Muir A, Fitzgerald LR, Hervieu G, Dytko GM, Foley JJ, Martin J, Liu WS, Park J, Ellis C, Ganguly S, Konchar S, Cluderay J, Leslie R, Wilson S, Sarau HM (Jul 1999). "Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1". Nature. 400 (6741): 261–5. doi:10.1038/22313. PMID10421367.
Saito Y, Nothacker HP, Wang Z, Lin SH, Leslie F, Civelli O (Jul 1999). "Molecular characterization of the melanin-concentrating-hormone receptor". Nature. 400 (6741): 265–9. doi:10.1038/22321. PMID10421368.
Shimomura Y, Mori M, Sugo T, Ishibashi Y, Abe M, Kurokawa T, Onda H, Nishimura O, Sumino Y, Fujino M (Aug 1999). "Isolation and identification of melanin-concentrating hormone as the endogenous ligand of the SLC-1 receptor". Biochemical and Biophysical Research Communications. 261 (3): 622–6. doi:10.1006/bbrc.1999.1104. PMID10441476.
Dunham I, Shimizu N, Roe BA, Chissoe S, Hunt AR, Collins JE, Bruskiewich R, Beare DM, Clamp M, Smink LJ, Ainscough R, Almeida JP, Babbage A, Bagguley C, Bailey J, Barlow K, Bates KN, Beasley O, Bird CP, Blakey S, Bridgeman AM, Buck D, Burgess J, Burrill WD, O'Brien KP (Dec 1999). "The DNA sequence of human chromosome 22". Nature. 402 (6761): 489–95. doi:10.1038/990031. PMID10591208.
Macdonald D, Murgolo N, Zhang R, Durkin JP, Yao X, Strader CD, Graziano MP (Jul 2000). "Molecular characterization of the melanin-concentrating hormone/receptor complex: identification of critical residues involved in binding and activation". Molecular Pharmacology. 58 (1): 217–25. PMID10860944.
Bednarek MA, Feighner SD, Hreniuk DL, Palyha OC, Morin NR, Sadowski SJ, MacNeil DJ, Howard AD, Van der Ploeg LH (Aug 2001). "Short segment of human melanin-concentrating hormone that is sufficient for full activation of human melanin-concentrating hormone receptors 1 and 2". Biochemistry. 40 (31): 9379–86. doi:10.1021/bi010867p. PMID11478907.
Bednarek MA, Tan C, Hreniuk DL, Palyha OC, MacNeil DJ, Van Der Ploeg LH, Howard AD, Feighner SD (Apr 2002). "Synthesis and biological evaluation in vitro of a selective, high potency peptide agonist of human melanin-concentrating hormone action at human melanin-concentrating hormone receptor 1". The Journal of Biological Chemistry. 277 (16): 13821–6. doi:10.1074/jbc.M200563200. PMID11839762.
Audinot V, Lahaye C, Suply T, Rovère-Jovène C, Rodriguez M, Nicolas JP, Beauverger P, Cardinaud B, Galizzi JP, Fauchère JL, Nahon JL, Boutin JA (Jul 2002). "SVK14 cells express an MCH binding site different from the MCH1 or MCH2 receptor". Biochemical and Biophysical Research Communications. 295 (4): 841–8. doi:10.1016/S0006-291X(02)00763-5. PMID12127971.
Hoogduijn MJ, Ancans J, Suzuki I, Estdale S, Thody AJ (Aug 2002). "Melanin-concentrating hormone and its receptor are expressed and functional in human skin". Biochemical and Biophysical Research Communications. 296 (3): 698–701. doi:10.1016/S0006-291X(02)00932-4. PMID12176038.
Bächner D, Kreienkamp HJ, Richter D (Aug 2002). "MIZIP, a highly conserved, vertebrate specific melanin-concentrating hormone receptor 1 interacting zinc-finger protein". FEBS Letters. 526 (1–3): 124–8. doi:10.1016/S0014-5793(02)03115-0. PMID12208518.
Verlaet M, Adamantidis A, Coumans B, Chanas G, Zorzi W, Heinen E, Grisar T, Lakaye B (Sep 2002). "Human immune cells express ppMCH mRNA and functional MCHR1 receptor". FEBS Letters. 527 (1–3): 205–10. doi:10.1016/S0014-5793(02)03232-5. PMID12220661.
Logan DW, Bryson-Richardson RJ, Pagán KE, Taylor MS, Currie PD, Jackson IJ (Feb 2003). "The structure and evolution of the melanocortin and MCH receptors in fish and mammals". Genomics. 81 (2): 184–91. doi:10.1016/S0888-7543(02)00037-X. PMID12620396.
Pissios P, Trombly DJ, Tzameli I, Maratos-Flier E (Aug 2003). "Melanin-concentrating hormone receptor 1 activates extracellular signal-regulated kinase and synergizes with G(s)-coupled pathways". Endocrinology. 144 (8): 3514–23. doi:10.1210/en.2002-0004. PMID12865333.
Gottumukkala RV, Waterman EA, Herd LM, Gawkrodger DJ, Watson PF, Weetman AP, Kemp EH (Oct 2003). "Autoantibodies in vitiligo patients recognize multiple domains of the melanin-concentrating hormone receptor". The Journal of Investigative Dermatology. 121 (4): 765–70. doi:10.1046/j.1523-1747.2003.12494.x. PMID14632194.
Gibson WT, Pissios P, Trombly DJ, Luan J, Keogh J, Wareham NJ, Maratos-Flier E, O'Rahilly S, Farooqi IS (May 2004). "Melanin-concentrating hormone receptor mutations and human obesity: functional analysis". Obesity Research. 12 (5): 743–9. doi:10.1038/oby.2004.89. PMID15166293.
Hawes BE, Green B, O'Neill K, Fried S, Arreaza MG, Qiu P, Simon JS (Aug 2004). "Identification and characterization of single-nucleotide polymorphisms in MCH-R1 and MCH-R2". Obesity Research. 12 (8): 1327–34. doi:10.1038/oby.2004.167. PMID15340116.